Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | +0.19% | -7.80% | +14.20% |
Mar. 14 | Top Premarket Gainers | MT |
Mar. 13 | Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.20% | 17.3M | |
+25.74% | 42.68B | |
-2.84% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.05% | 24.94B | |
-20.29% | 18.96B | |
+29.37% | 12.3B | |
-2.69% | 11.95B | |
-1.36% | 11.55B |
- Stock Market
- Equities
- INDP Stock
- News Indaptus Therapeutics, Inc.
- Indaptus Therapeutics : Maxim Group Upgrades Indaptus Therapeutics to Buy Rating From Hold, Sets $16 Price Target